• Antibodies to HHV-6 during acute COVID-19 may help predict development of Long COVID

    Autoantibodies directed against neural targets have most predictive power.

  • iciHHV-6B linked to systemic lupus erythematosus (SLE) in Japanese and European populations

    iciHHV-6B, when integrated into chromosome 22q, was strongly associated with SLE and with SLE severity.

  • HHV-6 linked to miscarriage through Mendelian randomization studies

    The findings are consistent with previous studies directly linking HHV-6 endometrial infection to miscarriage.

  • Finnish investigators find unexpected evidence of HHV-6B integration into mitochondrial DNA

    Could HHV-6B infection exacerbate mitochondrial disease?

Newsletter | About Us | Contact Us | Donate | Repository

HHV-6 Foundation | HHV-6 Disease Information for Patients, Clinicians, and Researchers | Apply for a Grant Navigation
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter

Latest HHV-6 Research Articles

View Post

Part 4. Might HHV-6 contribute to some cases of cytokine release syndrome, pneumonia, and cytopenias in CAR-T Cell therapy?

In All, Cancer, Immunity & Immunotherapy, Transplant Complications by Kristin LoomisNovember 26, 2023

While unlikely to trigger the cytokine storm, HHV-6 infection may perpetuate it, and contribute directly to cytopenias and pneumonia.

View Post

Early HHV-6 specific T-cell responses by ELISpot were remarkably higher in alloHSCT patients who went on to develop clinically relevant infections

In All, Immunity & Immunotherapy, Transplant Complications by Kristin LoomisOctober 31, 2023

T-cell responses correlate directly with clinical symptoms, and were better predictors of HHV-6 disease than viral load or total CD3+ counts.

View Post

Increased expression of HHV-6B receptor CD134/OX40 found in DIHS/DRESS skin lesions

In All, Drug Hypersensitivity, Transplant Complications by Kristin LoomisOctober 31, 2023

The severity of DIHS/DRESS cases was significantly correlated with the frequency of CD134+ cells.

View Post

Thorough review of the role of HHV-6 in DIHS/DRESS

In All, Drug Hypersensitivity by Kristin LoomisOctober 31, 2023

HHV-6 reactivation much more frequent than reactivation of other herpesviruses.

View Post

Review: HHV-6 is an important cause of persistent viral myocarditis, along with Parvovirus B-19 and adenovirus

In All, Heart Disease by Kristin LoomisOctober 31, 2023

SARS CoV-2 may lead to the activation of persistent herpesviruses in heart tissue.

View Post

Investigators find HHV-6 in the skin of DRESS patients two weeks before it is found in the blood in a large, multi-center case series

In All, Drug Hypersensitivity by Kristin LoomisSeptember 28, 2023

HHV-6 reactivation in both skin and blood was found frequently in severe cases.

View Post

Translation of HHV-6B U20 gene product characterized

In All, Genes by Kristin LoomisSeptember 28, 2023

Findings suggest role in evading host immune defenses.

View Post

EBV DNA found in 42% of lupus patients compared to 3% of controls; 25% had EBV IgM antibodies compared to <1% of controls

In All, Autoimmune Disease by Kristin LoomisSeptember 28, 2023

HHV-6 DNA is not elevated in lupus patients but may have a role in reactivating EBV.

View Post

Review of the theory that chronic viral infection of the brain can lead to depression

In All, CNS Disease by Kristin LoomisSeptember 28, 2023

Role of several viruses, including HHV-6A/B, in stimulating low-grade neuroinflammation.

View Post

Short-course foscarnet at an early stage may suppress HHV-6 reactivation following allogenic HCT

In All, Antiviral, Transplant Complications by Kristin LoomisAugust 3, 2023

Observational study suggests that an early one-week treatment at the first sign of viral reactivation may achieve clinical benefits and avoid antiviral toxicity.

View Post

COVID-19 patients with HHV-6 DNA and CNS symptoms showed increased expression of miR-155

In All, COVID, COVID-19 / HHV-6 Reactivation, Genes by Kristin LoomisAugust 29, 2023

Both HHV-6 and specific microRNAs may correlate with neurological symptoms in COVID-19.

View Post

Accurate Multiplex Assay for Viral Causes of Vesicular Diseases

In All, Rash & Roseola by Kristin LoomisAugust 29, 2023

Assay for monkeypox virus, HSV1-2, HHV-6, VZV and enteroviruses.

View Post

Herpesvirus Reactivation Common in Severe COVID-19

In All, COVID, COVID-19 / HHV-6 Reactivation by Kristin LoomisAugust 3, 2023

HHV-6 was the most common herpesvirus found when tested in nasal swabs, but EBV was the most common in plasma.

View Post

Systematic review of pityriasis rosea following COVID-19 and/or vaccination

In All, COVID, COVID-19 / HHV-6 Reactivation, Rash & Roseola by Kristin LoomisAugust 29, 2023

Pityriasis rosea was reported more frequently after vaccination than during or after acute infection.

View Post

HHV-6 DNA load in whole blood and elevated EBNA antibodies predict progression in first clinical episodes of demyelination in multiple sclerosis

In All, CNS Disease, Multiple Sclerosis by Kristin LoomisAugust 4, 2023

Patients with viral loads suggestive of iciHHV-6 had the greatest risk of developing demyelinating disease.

  • Page 6 of 38
  • ←
  • 1
  • ...
  • 5
  • 6
  • 7
  • ...
  • 38
  • →

Clinical News

  • Alzheimer’s Disease
  • Animal Models
  • Autoimmune Disease
  • Cancer
  • iciHHV-6
  • CNS Disease
  • COVID-19 / HHV-6 Reactivation
  • Drug Hypersensitivity
  • Encephalitis & Encephalopathy
  • Endocrine Conditions
  • Epilepsy and Seizures
  • Gastrointestinal
  • Genes
  • Heart Disease
  • Hematological Disorders
  • HIV/AIDS Progression
  • Immunity & Immunotherapy
  • Infertility & Miscarriage
  • Kidney Disease
  • Liver Disease
  • Lung Disease
  • Lymphadenopathy & Fever
  • ME/CFS
  • Multiple Sclerosis
  • Rash & Roseola
  • Transplant Complications
  • Treatments – Adoptive T cell
  • Treatments – Alternative
  • Treatments – Antiviral
  • Treatments – Immune Stimulant

About HHV-6

  • What Is HHV-6?
  • What is Inherited Chromosomally Integrated HHV-6
  • HHV-6 Repository of Reagents
  • HHV-6A/B Testing
  • HHV-6 Treatment

SUBSCRIBE TO OUR NEWSLETTER

ABOUT THE HHV-6 FOUNDATION

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B.

The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge.

Read More

HHV-6 Foundation | 1482 East Valley Road, Suite 619 | Santa Barbara, CA, 93108 | Toll Free: (888) 530-6726


Copyright ©2004-2022 HHV-6 FOUNDATION


WEB DESIGN AND DEVELOPMENT BY INSTYLE TECHNOLOGIES
  • Home
  • About
  • Conditions
  • Clinicians
  • Testing
  • Research
  • Repository
  • Patients
  • Treatment
  • News & Blog
  • Donate
  • Contact Us
  • Cart
  • Checkout
  • Privacy Policy
  • Terms of Use